{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T07:58:35Z","timestamp":1703663915527},"reference-count":27,"publisher":"ALUNA","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Autoimmune encephalitis (AE) is a non-infectious inflammatory disease caused by the presence of autoantibodies directed against neuronal surface or intracellular antigens. Its incidence in Western countries is about 0.8 per 100,000 people. AE requires differentiation primarily with psychiatric diseases, but it also requires oncological vigilance. On the other hand, in the case of an acute episode of psychosis, differentiation with AE should always be pursued. This paper discusses the most common psychiatric disorders that occur in autoimmune encephalitis.<\/jats:p>","DOI":"10.36740\/merkur202305117","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T19:07:04Z","timestamp":1702148824000},"page":"563-568","source":"Crossref","is-referenced-by-count":1,"title":["PSYCHIATRIC DISORDERS IN AUTOIMMUNE ENCEPHALITIS \u2013 LITERATURE REVIEW"],"prefix":"10.36740","volume":"51","author":[{"given":"Sandra","family":"Wcis\u0142o","sequence":"first","affiliation":[{"name":"STUDENT SCIENTIFIC ASSOCIATION AT THE DEPARTMENT OF NEUROLOGY, INSTITUTE OF MEDICAL SCIENCES, UNIVERSITY OF OPOLE, OPOLE, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Bojkowska-Otr\u0119bska","sequence":"additional","affiliation":[{"name":"CLINICAL DEPARTMENT OF GERIATRICS, INSTITUTE OF MEDICAL SCIENCES, UNIVERSITY OF OPOLE, OPOLE, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"\u0141abuz-Roszak","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF NEUROLOGY, INSTITUTE OF MEDICAL SCIENCES, UNIVERSITY OF OPOLE, OPOLE, POLAND; DEPARTMENT OF NEUROLOGY, ST. JADWIGA REGIONAL SPECIALIZED HOSPITAL, OPOLE, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. Goodfellow JA, Mackay GA. Autoimmune encephalitis. J R Coll Physicians Edinb. 2019;49(4):287-294.","DOI":"10.4997\/jrcpe.2019.407"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045-1057.","DOI":"10.1016\/s1474-4422(19)30244-3"},{"key":"ref2","unstructured":"3. \u017bur-Wyrozumska K. Autoimmunologiczne zapalenie m\u00f3zgu zwi\u0105zane z przeciwcia\u0142ami przeciwko neuronalnym antygenom powierzchniowym \u2013 \u015bcie\u017cka diagnostyczno-terapeutyczna dla lekarza praktyka. Med Prakt. Neurologia. 2021;1:27-31. (Polish)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015; 15(12): 1391-419.","DOI":"10.1586\/14737175.2015.1115720"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Newman MP, Blum S, Wong RC, et al. Autoimmune encephalitis. Intern Med J. 2019;46(2):148-157.","DOI":"10.1111\/imj.12974"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Pollak TA, Lennox BR, M\u00fcller S, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93-108.","DOI":"10.1016\/s2215-0366(19)30290-1"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157-165.","DOI":"10.1016\/s1474-4422(12)70310-1"},{"key":"ref8","unstructured":"9. Zajkowska J, Ustymowicz A, Kondrusik M. Opryszczkowe zapalenie m\u00f3zgu \u2013 trudno\u015bci diagnostyczne. Neurol Dypl. 2013;8(2):24-36. (Polish)"},{"key":"ref9","unstructured":"10. Go\u0142\u0105b-Janowska M, Nowacki P. Limbiczne zapalenie m\u00f3zgu \u2013 przegl\u0105d pi\u015bmiennictwa. Annales Academiae Medicae Stetinensis 2011;57(3):5-11. (Polish)"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70:1133-1139.","DOI":"10.1001\/jamaneurol.2013.3216"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti\u00ac-NMDAR encephalitis. Lancet Neurol. 2011;10:63-74.","DOI":"10.1016\/s1474-4422(10)70253-2"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR. Psychosis: an autoimmune disease? Immunology. 2017;152(3):388-401.","DOI":"10.1111\/imm.12795"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Rathore GS, Leung KS, Muscal E. Autoimmune encephalitis following bone marrow transplantation. Pediatr Neurol. 2015;53:253-256.","DOI":"10.1016\/j.pediatrneurol.2015.05.011"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176(1):36-40.","DOI":"10.1016\/j.schres.2014.10.007"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70:271-278.","DOI":"10.1001\/2013.jamapsychiatry.86"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17. Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016;19:6-9.","DOI":"10.1136\/eb-2015-102117"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Wu PM, Teng CK, Chou YY, Tu YF. Precocious puberty as a consequence of anti-NMDA receptor encephalitis in children. Pediatr Neonatol. 2021;62(4):361-368.","DOI":"10.1016\/j.pedneo.2021.03.004"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Jones HF, Mohammad SS, Reed PW, et al. Anti-N-methyl-d-aspartate receptor encephalitis in M\u0101ori and Pacific Island children in New Zealand. Dev Med Child Neurol. 2017;59(7):719-724.","DOI":"10.1111\/dmcn.13420"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Pollak TA, McCormack R, Peakman M, Nicholson TR, David AS. Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med. 2014;44(12):2475-2487.","DOI":"10.1017\/s003329171300295x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Mu\u00f1oz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol. 2020;19(12):1010-1022.","DOI":"10.1016\/s1474-4422(20)30341-0"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol. 2021;21(5):412-423.","DOI":"10.1136\/practneurol-2020-002567"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Chung HY, Wickel J, Voss A, et al. Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report. Medicine (Baltimore). 2021;98(20):e15706.","DOI":"10.1097\/md.0000000000015706"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Ralls F, Cutchen L, Grigg-Damberger MM. Recognizing new-onset sleep disorders in autoimmune encephalitis often prompt earlier diagnosis. J Clin Neu\u00acrophysiol. 2022;39(5):363-371.","DOI":"10.1097\/wnp.0000000000000820"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25. Liu X, Yu T, Zhao X, et al. Risk factors and brain metabolic mechanism of sleep disorders in autoimmune encephalitis. Front Immunol. 2021;12:738097.","DOI":"10.3389\/fimmu.2021.738097"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Diaz-Arias LA, Yeshokumar AK, Glassberg B, et al. Fatigue in survivors of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1064.","DOI":"10.1212\/nxi.0000000000001064"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Kayser MS, Kohler CG, Dalmau J. Psychiatric manifestations of paraneoplastic disorders. Am J Psychiatry. 2010;167:1039-1050.","DOI":"10.1176\/appi.ajp.2010.09101547"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T19:07:10Z","timestamp":1702148830000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2023i5.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]},"published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202305117","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}